PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinoma and Tumor-associated Immune Cells: Differences Between MLH1 Methylated and Nonmethylated Subgroups. | Int J Gynecol Pathol;40(6): 575-586, 2021 Nov 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinoma and Tumor-associated Immune Cells: Differences Between MLH1 Methylated and Nonmethylated Subgroups.

Kir, Gozde; Olgun, Zeynep C; Soylemez, Tuce; Aydin, Abdullah; Demircan, Berna; Kaya, Ibrahim A; McCluggage, W Glenn.

Int J Gynecol Pathol ; 40(6): 575-586, 2021 Nov 01.

Article in En | MEDLINE | ID: mdl-33332859

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms / DNA Mismatch Repair Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Int J Gynecol Pathol Year: 2021 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms / DNA Mismatch Repair Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Int J Gynecol Pathol Year: 2021 Document type: Article Country of publication: